53 assets in Non-Small Cell Squamous Lung Carcinoma

Carboplatin

Pembrolizumab

Serplulimab

Cis-Diamminedichloroplatinum Ii

Docetaxel

Tislelizumab

Catequentinib

Benmelstobart

Nivolumab

Domvanalimab

hlx43

Patritumab Deruxtecan

Pimurutamab

Zimberelimab

Lenvatinib

Atezolizumab

Cabozantinib

Durvalumab

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Olvimulogene Nanivacirepvec

pf-08634404

Prednisone

Trilaciclib

a2b543

a2b694

Berzosertib

gi-101a

Human T-Lymphocyte Activation Antigen Cd80 (Activation B7-1 Antigen, Ctla-4 Counter-Receptor B7.1, Cd80) Extracellular Domain Containing Fragment (1-208 In The Current Sequence) Fused Via Peptide Linker <Sup>209</Sup>Gsggggsggggsggggs<Sup>225</Sup> To An Fc Fragment Of Human Immunoglobulin G4 (226-454) [Homo Sapiens Ighg4*01, Hinge Ins<Sup>226</Sup>>A, S<Sup>236</Sup>>P (226-238), Ch2 F<Sup>242</Sup>>A, L<Sup>243</Sup>>A, T<Sup>258</Sup>>Q (239-348), Ch3 M<Sup>436</Sup>>L (349-453), Chs K<Sup>455</Sup>>Del (454)] Fused Via Peptide/ Linker <Sup>455</Sup>Ggggs<Sup>459</Sup> To Human Interleukin-2 (Il-2, T-Cell Growth Factor (Tcgf)) (1-133, 460-592 In The Current Sequence), Variant (R<Sup>38</Sup>>A<Sup>497</Sup>, F<Sup>42</Sup>>A<Sup>501</Sup>), Dimer (234-234', 237-237')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa

Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain

Silevertinib

[177lu]lu-dpi-4452

[68ga]ga-dpi-4452

a2b530

Atamparib

Cetuximab

Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-31*01 (89.9%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (85.3%)-Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa

Montanide Isa 51

Recombinant Human Egf-Rp64K

Abbv-324

Bgb-B2033

CV09070101 mRNA vaccine (CVHNLC)

Cyclophosphamide

Fludarabine

hdm2020

hlx35

LY3143921

Mytx-011

nxp900

Zi-Ma4-1

Bemarituzumab